BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2540511)

  • 1. Suppression of salt intake in the rat by neurokinin A: comparison with the effect of kassinin.
    Massi M; Epstein AN
    Regul Pept; 1989 Mar; 24(3):233-44. PubMed ID: 2540511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of kassinin on salt intake induced by different natriorexigenic treatments in the rat.
    Massi M; Perfumi M; de Caro G; Epstein AN
    Brain Res; 1988 Feb; 440(2):232-42. PubMed ID: 3282606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of salt appetite in the rat following injection of tachykinins into the medial amygdala.
    Massi M; Gentili L; Perfumi M; de Caro G; Schulkin J
    Brain Res; 1990 Apr; 513(1):1-7. PubMed ID: 1693538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central tachykinin injection potently suppresses the need-free salt intake of the female rat.
    Massi M; Gentili L; Pompei P; de Caro G; Epstein AN
    Brain Res; 1992 Jul; 584(1-2):77-82. PubMed ID: 1325251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bed nucleus of the stria terminalis: site for the antinatriorexic action of tachykinins in the rat.
    Pompei P; Tayebaty SJ; De Caro G; Schulkin J; Massi M
    Pharmacol Biochem Behav; 1991 Dec; 40(4):977-81. PubMed ID: 1816584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
    Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
    Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development in infant rats of kassinin's potent and selective control of cell-dehydration thirst.
    Perfumi M; Massi M; Costa G; Epstein AN; de Caro G
    Peptides; 1989; 10(1):125-30. PubMed ID: 2748416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in neurokinin-3 tachykinin receptor-immunoreactive and -mRNA levels are associated with salt appetite in the deoxycorticosterone-treated rat.
    Lucas LR; Reagan LP; Akama KT; Ma LY; Tamashiro KL; Sakai RR; McEwen BS
    Brain Res; 2003 Jan; 960(1-2):252-8. PubMed ID: 12505679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin A selectively inhibits water intake in the rat.
    Perfumi M; Polidori C; Massi M; de Caro G
    Neuropharmacology; 1988 Sep; 27(9):909-14. PubMed ID: 2847071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular injections of tachykinin NK3 receptor agonists affect salt intake. A shift in taste intensity?
    Smith ME; Flynn FW
    Ann N Y Acad Sci; 1999; 897():432-5. PubMed ID: 10676471
    [No Abstract]   [Full Text] [Related]  

  • 11. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of kassinin, neurokinin A and neurokinin B on drinking behaviour in the pigeon.
    Massi M; Perfumi M; Polidori C; de Caro G
    Regul Pept; 1987 Feb; 17(2):85-97. PubMed ID: 3033752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain tachykinins and the regulation of salt intake.
    Flynn FW
    Ann N Y Acad Sci; 1999; 897():173-81. PubMed ID: 10676446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the 5-HT2 antagonist ketanserin on salt appetite in the rat.
    Gentili L; Saija A; Luchetti G; Massi M
    Pharmacol Biochem Behav; 1991 May; 39(1):171-6. PubMed ID: 1924500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin.
    Andrews PV; Helme RD; Thomas KL
    Br J Pharmacol; 1989 Aug; 97(4):1232-8. PubMed ID: 2477105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors.
    Polidori C; Panocka I; Ciccocioppo R; Broccardo M; Improta G; Regoli D; Massi M
    Peptides; 1997; 18(6):825-33. PubMed ID: 9285931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of tachykinin-induced bronchoconstriction in the rat.
    Joos GF; Pauwels RA; van der Straeten ME
    Am Rev Respir Dis; 1988 May; 137(5):1038-44. PubMed ID: 2461668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the mechanisms of the tachykinin-induced activation of micturition reflex in rats: evidence for the involvement of the capsaicin-sensitive bladder mechanoreceptors.
    Maggi CA; Giuliani S; Santicioli P; Abelli L; Regoli D; Meli A
    Eur J Pharmacol; 1987 Apr; 136(2):189-205. PubMed ID: 2439357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors.
    Polidori C; Saija A; Perfumi M; Costa G; de Caro G; Massi M
    Neurosci Lett; 1989 Sep; 103(3):320-5. PubMed ID: 2478934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.